Shares of Hims & Hers Health Inc. (HIMS) surged 5.11% in Monday's pre-market session, following positive analyst coverage and raised price targets from Piper Sandler.
Analysts at Piper Sandler maintained a "Hold" rating on Hims & Hers Health but raised their price target on the stock from $21 to $24, reflecting potential growth opportunities for the company in the beauty and wellness sector.
While the firm highlighted interest rates, lending standards, and potential policies from the incoming administration as key factors to watch, it expressed optimism for U.S. beauty and wellness companies in 2025, positioning Hims & Hers Health as one of its top ideas for the year.